Clinical trial
Tandem Autologous Stem Cell Transplantation in Treating Patients With Primary…
NCT00075621 · Boston Medical Center, Other · Completed
Key facts
| NCT number | NCT00075621 |
|---|---|
| Title | Tandem Autologous Stem Cell Transplantation in Treating Patients With Primary Systemic (AL) Amyloidosis |
| Official title | A Phase II Trial of Tandem Transplantation in AL Amyloidosis |
| Lead sponsor | Boston Medical Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug, Procedure |
| Interventions | filgrastim, melphalan, autologous peripheral blood stem cell transplantation |
| Enrollment | 62 |
| Start date | Aug 1, 2000 |
| Primary completion | Jun 1, 2005 |
| Completion | Sep 4, 2020 |
| First posted | Jan 12, 2004 |
| Last update posted | Sep 17, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: